Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1Phase 2 1Phase 1 1

Status

Completed 51Terminated 13Unknown 8Recruiting 7Withdrawn 4Not yet recruiting 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 8

Sponsor

Cancer Type

Gastrointestinal 124Thoracic 55Lymphoid 35Head & Neck 31Breast 20Gynecologic 17Genitourinary 16Other solid neoplasm 11Tumor-Agnostic 8Sarcoma 3Other hematologic neoplasm 3Myeloid 2Dermatologic 2CNS 2Plasma cell 1Endocrine 1

Conditions

Neoplasms 3Neoplasm Metastasis 2Adenocarcinoma 2Neoplasms, Unknown Primary 1Carcinoma 1

Interventions

Radiotherapy 9Drug Therapy 9Cisplatin 9Gemcitabine 8Docetaxel 7Carboplatin 7Blood Specimen Collection 7Nivolumab 6Fluorouracil 6Pemetrexed 5Capecitabine 5pembrolizumab 4Surveys and Questionnaires 4Positron Emission Tomography Computed Tomography 4Paclitaxel 4Oxaliplatin 4Exercise 4Everolimus 4Data Collection 4Cetuximab 4indibulin 3icotinib 3Vincristine 3Trastuzumab 3Standard of Care 3Radiosurgery 3Neoadjuvant Therapy 3Magnetic Resonance Spectroscopy 3Interleukin-2 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Unknown × Gemcitabine × Tumor-Agnostic × Clear all
NCT04652206 2021-12-29

PANTAX-Ib

Scandion Oncology A/S

Phase 1/2 Unknown
18 enrolled
Tumor-Agnostic

Neoplasms

NCT03669601 2021-06-04

ATRiUM

Cambridge University Hospitals NHS Foundation Trust

Phase 1 Unknown
55 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04167007 2020-08-18

GEMFOX

Assistance Publique - Hôpitaux de Paris

Phase 3 Unknown
400 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02863471 2017-10-31

PanHIPEC

University Hospital Tuebingen

Phase 1/2 Unknown
16 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT02590055 2015-10-28

Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

Samsung Medical Center

Phase 2 Unknown
29 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT02194556 2014-07-18

Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC

Betta Pharmaceuticals Co., Ltd.

Phase 4 Unknown
100 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT01713218 2012-10-24

NEOPACHI-001

Erasme University Hospital

Phase EARLY_PHASE1 Unknown
21 enrolled
Tumor-Agnostic

Neoplasms

NCT00126269 2006-09-08

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown
192 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡